nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—OPRK1—alcohol dependence	0.185	0.394	CbGaD
Tapentadol—OPRD1—alcohol dependence	0.131	0.277	CbGaD
Tapentadol—OPRD1—Naltrexone—alcohol dependence	0.1	0.27	CbGbCtD
Tapentadol—OPRM1—alcohol dependence	0.1	0.212	CbGaD
Tapentadol—OPRK1—Naltrexone—alcohol dependence	0.084	0.226	CbGbCtD
Tapentadol—OPRM1—Naltrexone—alcohol dependence	0.0741	0.199	CbGbCtD
Tapentadol—SLC6A4—alcohol dependence	0.0551	0.117	CbGaD
Tapentadol—SLC6A4—Citalopram—alcohol dependence	0.0406	0.109	CbGbCtD
Tapentadol—SLC6A2—Citalopram—alcohol dependence	0.0339	0.0912	CbGbCtD
Tapentadol—CYP2C9—Disulfiram—alcohol dependence	0.0156	0.0419	CbGbCtD
Tapentadol—CYP2C19—Citalopram—alcohol dependence	0.0134	0.0359	CbGbCtD
Tapentadol—CYP2D6—Citalopram—alcohol dependence	0.0102	0.0273	CbGbCtD
Tapentadol—SLC6A2—locus ceruleus—alcohol dependence	0.0029	0.103	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—alcohol dependence	0.00154	0.0549	CbGeAlD
Tapentadol—HTR3A—nerve—alcohol dependence	0.00129	0.046	CbGeAlD
Tapentadol—OPRM1—nerve—alcohol dependence	0.00118	0.0422	CbGeAlD
Tapentadol—Phenylephrine—MAOA—alcohol dependence	0.00105	1	CrCbGaD
Tapentadol—SLC6A2—nerve—alcohol dependence	0.000867	0.0309	CbGeAlD
Tapentadol—Muscle contractions involuntary—Citalopram—alcohol dependence	0.000736	0.00919	CcSEcCtD
Tapentadol—Abdominal discomfort—Disulfiram—alcohol dependence	0.000725	0.00905	CcSEcCtD
Tapentadol—OPRD1—forebrain—alcohol dependence	0.00072	0.0256	CbGeAlD
Tapentadol—Erectile dysfunction—Disulfiram—alcohol dependence	0.000696	0.00869	CcSEcCtD
Tapentadol—OPRK1—forebrain—alcohol dependence	0.00069	0.0245	CbGeAlD
Tapentadol—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.000683	0.00852	CcSEcCtD
Tapentadol—Balance disorder—Citalopram—alcohol dependence	0.000651	0.00812	CcSEcCtD
Tapentadol—Thinking abnormal—Acamprosate—alcohol dependence	0.000648	0.00809	CcSEcCtD
Tapentadol—Disturbance in attention—Naltrexone—alcohol dependence	0.000648	0.00809	CcSEcCtD
Tapentadol—UGT1A9—digestive system—alcohol dependence	0.000639	0.0227	CbGeAlD
Tapentadol—Sexual dysfunction—Citalopram—alcohol dependence	0.000635	0.00792	CcSEcCtD
Tapentadol—Thinking abnormal—Naltrexone—alcohol dependence	0.000614	0.00766	CcSEcCtD
Tapentadol—Hypoaesthesia—Disulfiram—alcohol dependence	0.000602	0.00752	CcSEcCtD
Tapentadol—Abnormal dreams—Acamprosate—alcohol dependence	0.000587	0.00732	CcSEcCtD
Tapentadol—Abnormal dreams—Naltrexone—alcohol dependence	0.000555	0.00693	CcSEcCtD
Tapentadol—HTR3A—brainstem—alcohol dependence	0.000555	0.0197	CbGeAlD
Tapentadol—Nightmare—Naltrexone—alcohol dependence	0.000542	0.00677	CcSEcCtD
Tapentadol—HTR3A—forebrain—alcohol dependence	0.000535	0.019	CbGeAlD
Tapentadol—UGT1A9—endocrine gland—alcohol dependence	0.000528	0.0188	CbGeAlD
Tapentadol—Mental disability—Acamprosate—alcohol dependence	0.000515	0.00643	CcSEcCtD
Tapentadol—UGT2B7—digestive system—alcohol dependence	0.000515	0.0183	CbGeAlD
Tapentadol—OPRM1—brainstem—alcohol dependence	0.000508	0.0181	CbGeAlD
Tapentadol—Suicidal ideation—Citalopram—alcohol dependence	0.000507	0.00633	CcSEcCtD
Tapentadol—OPRM1—forebrain—alcohol dependence	0.000491	0.0175	CbGeAlD
Tapentadol—Mental disability—Naltrexone—alcohol dependence	0.000487	0.00608	CcSEcCtD
Tapentadol—Euphoric mood—Naltrexone—alcohol dependence	0.000483	0.00602	CcSEcCtD
Tapentadol—UGT1A9—liver—alcohol dependence	0.000476	0.0169	CbGeAlD
Tapentadol—Disorientation—Naltrexone—alcohol dependence	0.000456	0.00569	CcSEcCtD
Tapentadol—Feeling hot—Citalopram—alcohol dependence	0.000453	0.00566	CcSEcCtD
Tapentadol—Memory impairment—Citalopram—alcohol dependence	0.000453	0.00566	CcSEcCtD
Tapentadol—Hot flush—Naltrexone—alcohol dependence	0.000436	0.00544	CcSEcCtD
Tapentadol—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.000433	0.0054	CcSEcCtD
Tapentadol—Menopausal symptoms—Naltrexone—alcohol dependence	0.000432	0.00539	CcSEcCtD
Tapentadol—UGT2B7—endocrine gland—alcohol dependence	0.000426	0.0151	CbGeAlD
Tapentadol—SLC6A4—brainstem—alcohol dependence	0.000423	0.015	CbGeAlD
Tapentadol—Lethargy—Naltrexone—alcohol dependence	0.000416	0.00519	CcSEcCtD
Tapentadol—Disturbance in attention—Citalopram—alcohol dependence	0.000411	0.00513	CcSEcCtD
Tapentadol—SLC6A4—forebrain—alcohol dependence	0.000408	0.0145	CbGeAlD
Tapentadol—UGT2B7—testis—alcohol dependence	0.000406	0.0144	CbGeAlD
Tapentadol—OPRD1—nervous system—alcohol dependence	0.000391	0.0139	CbGeAlD
Tapentadol—Breast disorder—Acamprosate—alcohol dependence	0.000389	0.00486	CcSEcCtD
Tapentadol—Irritability—Naltrexone—alcohol dependence	0.000389	0.00486	CcSEcCtD
Tapentadol—Thinking abnormal—Citalopram—alcohol dependence	0.000389	0.00485	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.000388	0.00484	CcSEcCtD
Tapentadol—Paraesthesia—Disulfiram—alcohol dependence	0.000386	0.00482	CcSEcCtD
Tapentadol—UGT2B7—liver—alcohol dependence	0.000384	0.0137	CbGeAlD
Tapentadol—Drug interaction—Citalopram—alcohol dependence	0.000384	0.00479	CcSEcCtD
Tapentadol—Somnolence—Disulfiram—alcohol dependence	0.000382	0.00477	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00038	0.00474	CcSEcCtD
Tapentadol—Dysarthria—Citalopram—alcohol dependence	0.000376	0.0047	CcSEcCtD
Tapentadol—OPRD1—central nervous system—alcohol dependence	0.000376	0.0134	CbGeAlD
Tapentadol—HTR3A—digestive system—alcohol dependence	0.000376	0.0134	CbGeAlD
Tapentadol—OPRK1—nervous system—alcohol dependence	0.000374	0.0133	CbGeAlD
Tapentadol—SLC6A2—brainstem—alcohol dependence	0.000372	0.0132	CbGeAlD
Tapentadol—Fatigue—Disulfiram—alcohol dependence	0.000371	0.00463	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.000367	0.00458	CcSEcCtD
Tapentadol—Nasopharyngitis—Naltrexone—alcohol dependence	0.000365	0.00455	CcSEcCtD
Tapentadol—Coordination abnormal—Citalopram—alcohol dependence	0.000362	0.00452	CcSEcCtD
Tapentadol—OPRK1—central nervous system—alcohol dependence	0.000361	0.0128	CbGeAlD
Tapentadol—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00036	0.00449	CcSEcCtD
Tapentadol—SLC6A2—forebrain—alcohol dependence	0.000359	0.0128	CbGeAlD
Tapentadol—HTR3A—blood—alcohol dependence	0.000358	0.0127	CbGeAlD
Tapentadol—OPRK1—cerebellum—alcohol dependence	0.000352	0.0125	CbGeAlD
Tapentadol—Abnormal dreams—Citalopram—alcohol dependence	0.000352	0.00439	CcSEcCtD
Tapentadol—Pollakiuria—Acamprosate—alcohol dependence	0.000344	0.00429	CcSEcCtD
Tapentadol—Nightmare—Citalopram—alcohol dependence	0.000344	0.00429	CcSEcCtD
Tapentadol—Depressed level of consciousness—Citalopram—alcohol dependence	0.000344	0.00429	CcSEcCtD
Tapentadol—Erectile dysfunction—Acamprosate—alcohol dependence	0.000343	0.00428	CcSEcCtD
Tapentadol—Abdominal discomfort—Naltrexone—alcohol dependence	0.000338	0.00422	CcSEcCtD
Tapentadol—Weight decreased—Acamprosate—alcohol dependence	0.000337	0.00421	CcSEcCtD
Tapentadol—Depression—Acamprosate—alcohol dependence	0.000331	0.00413	CcSEcCtD
Tapentadol—OPRM1—blood—alcohol dependence	0.000328	0.0117	CbGeAlD
Tapentadol—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000327	0.00409	CcSEcCtD
Tapentadol—OPRM1—midbrain—alcohol dependence	0.000324	0.0115	CbGeAlD
Tapentadol—Urinary tract infection—Acamprosate—alcohol dependence	0.000323	0.00403	CcSEcCtD
Tapentadol—Weight decreased—Naltrexone—alcohol dependence	0.000319	0.00398	CcSEcCtD
Tapentadol—Infestation NOS—Naltrexone—alcohol dependence	0.000314	0.00392	CcSEcCtD
Tapentadol—Infestation—Naltrexone—alcohol dependence	0.000314	0.00392	CcSEcCtD
Tapentadol—Depression—Naltrexone—alcohol dependence	0.000313	0.00391	CcSEcCtD
Tapentadol—Mental disability—Citalopram—alcohol dependence	0.000309	0.00385	CcSEcCtD
Tapentadol—Asthenia—Disulfiram—alcohol dependence	0.000308	0.00385	CcSEcCtD
Tapentadol—Euphoric mood—Citalopram—alcohol dependence	0.000306	0.00382	CcSEcCtD
Tapentadol—Urinary tract infection—Naltrexone—alcohol dependence	0.000305	0.00381	CcSEcCtD
Tapentadol—OPRD1—brain—alcohol dependence	0.000299	0.0106	CbGeAlD
Tapentadol—Hypoaesthesia—Acamprosate—alcohol dependence	0.000297	0.0037	CcSEcCtD
Tapentadol—Hallucination—Acamprosate—alcohol dependence	0.000297	0.0037	CcSEcCtD
Tapentadol—HTR3A—nervous system—alcohol dependence	0.000291	0.0103	CbGeAlD
Tapentadol—Disorientation—Citalopram—alcohol dependence	0.000289	0.0036	CcSEcCtD
Tapentadol—Visual impairment—Acamprosate—alcohol dependence	0.000287	0.00359	CcSEcCtD
Tapentadol—SLC6A4—digestive system—alcohol dependence	0.000286	0.0102	CbGeAlD
Tapentadol—OPRK1—brain—alcohol dependence	0.000286	0.0102	CbGeAlD
Tapentadol—OPRM1—endocrine gland—alcohol dependence	0.000285	0.0101	CbGeAlD
Tapentadol—Dizziness—Disulfiram—alcohol dependence	0.000284	0.00355	CcSEcCtD
Tapentadol—Hallucination—Naltrexone—alcohol dependence	0.000281	0.0035	CcSEcCtD
Tapentadol—HTR3A—central nervous system—alcohol dependence	0.00028	0.00995	CbGeAlD
Tapentadol—Connective tissue disorder—Naltrexone—alcohol dependence	0.000277	0.00346	CcSEcCtD
Tapentadol—Hot flush—Citalopram—alcohol dependence	0.000276	0.00345	CcSEcCtD
Tapentadol—SLC6A2—gonad—alcohol dependence	0.000276	0.00981	CbGeAlD
Tapentadol—Menopausal symptoms—Citalopram—alcohol dependence	0.000274	0.00342	CcSEcCtD
Tapentadol—SLC6A4—blood—alcohol dependence	0.000273	0.00971	CbGeAlD
Tapentadol—Visual disturbance—Citalopram—alcohol dependence	0.000273	0.0034	CcSEcCtD
Tapentadol—OPRM1—testis—alcohol dependence	0.000271	0.00966	CbGeAlD
Tapentadol—Rash—Disulfiram—alcohol dependence	0.000271	0.00338	CcSEcCtD
Tapentadol—SLC6A4—midbrain—alcohol dependence	0.00027	0.00959	CbGeAlD
Tapentadol—Headache—Disulfiram—alcohol dependence	0.000269	0.00336	CcSEcCtD
Tapentadol—Immune system disorder—Acamprosate—alcohol dependence	0.000269	0.00336	CcSEcCtD
Tapentadol—Chills—Acamprosate—alcohol dependence	0.000267	0.00334	CcSEcCtD
Tapentadol—OPRM1—nervous system—alcohol dependence	0.000266	0.00948	CbGeAlD
Tapentadol—Lethargy—Citalopram—alcohol dependence	0.000264	0.00329	CcSEcCtD
Tapentadol—Eye disorder—Naltrexone—alcohol dependence	0.000264	0.00329	CcSEcCtD
Tapentadol—Cardiac disorder—Naltrexone—alcohol dependence	0.000262	0.00327	CcSEcCtD
Tapentadol—Mental disorder—Acamprosate—alcohol dependence	0.000261	0.00326	CcSEcCtD
Tapentadol—Malnutrition—Acamprosate—alcohol dependence	0.000259	0.00324	CcSEcCtD
Tapentadol—Osteoarthritis—Citalopram—alcohol dependence	0.000258	0.00322	CcSEcCtD
Tapentadol—OPRM1—central nervous system—alcohol dependence	0.000256	0.00913	CbGeAlD
Tapentadol—Angiopathy—Naltrexone—alcohol dependence	0.000256	0.00319	CcSEcCtD
Tapentadol—Immune system disorder—Naltrexone—alcohol dependence	0.000255	0.00318	CcSEcCtD
Tapentadol—Tension—Acamprosate—alcohol dependence	0.000255	0.00318	CcSEcCtD
Tapentadol—Mediastinal disorder—Naltrexone—alcohol dependence	0.000254	0.00317	CcSEcCtD
Tapentadol—Chills—Naltrexone—alcohol dependence	0.000253	0.00316	CcSEcCtD
Tapentadol—Nervousness—Acamprosate—alcohol dependence	0.000252	0.00315	CcSEcCtD
Tapentadol—Mental disorder—Naltrexone—alcohol dependence	0.000247	0.00308	CcSEcCtD
Tapentadol—Irritability—Citalopram—alcohol dependence	0.000247	0.00308	CcSEcCtD
Tapentadol—Malnutrition—Naltrexone—alcohol dependence	0.000246	0.00306	CcSEcCtD
Tapentadol—Tremor—Acamprosate—alcohol dependence	0.000243	0.00303	CcSEcCtD
Tapentadol—Ataxia—Citalopram—alcohol dependence	0.000243	0.00303	CcSEcCtD
Tapentadol—Tension—Naltrexone—alcohol dependence	0.000241	0.00301	CcSEcCtD
Tapentadol—Agitation—Acamprosate—alcohol dependence	0.000238	0.00298	CcSEcCtD
Tapentadol—Nervousness—Naltrexone—alcohol dependence	0.000238	0.00298	CcSEcCtD
Tapentadol—CYP2C19—digestive system—alcohol dependence	0.000237	0.00845	CbGeAlD
Tapentadol—Angioedema—Acamprosate—alcohol dependence	0.000237	0.00296	CcSEcCtD
Tapentadol—SLC6A4—endocrine gland—alcohol dependence	0.000237	0.00842	CbGeAlD
Tapentadol—Breast disorder—Citalopram—alcohol dependence	0.000233	0.00291	CcSEcCtD
Tapentadol—Vertigo—Acamprosate—alcohol dependence	0.000233	0.00291	CcSEcCtD
Tapentadol—Syncope—Acamprosate—alcohol dependence	0.000233	0.0029	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000233	0.0029	CcSEcCtD
Tapentadol—Vision blurred—Naltrexone—alcohol dependence	0.000231	0.00289	CcSEcCtD
Tapentadol—Nasopharyngitis—Citalopram—alcohol dependence	0.000231	0.00288	CcSEcCtD
Tapentadol—Tremor—Naltrexone—alcohol dependence	0.00023	0.00287	CcSEcCtD
Tapentadol—Palpitations—Acamprosate—alcohol dependence	0.000229	0.00286	CcSEcCtD
Tapentadol—Loss of consciousness—Acamprosate—alcohol dependence	0.000228	0.00285	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000228	0.00284	CcSEcCtD
Tapentadol—Cough—Acamprosate—alcohol dependence	0.000226	0.00283	CcSEcCtD
Tapentadol—CYP2C19—blood—alcohol dependence	0.000226	0.00805	CbGeAlD
Tapentadol—Agitation—Naltrexone—alcohol dependence	0.000226	0.00282	CcSEcCtD
Tapentadol—Convulsion—Acamprosate—alcohol dependence	0.000225	0.00281	CcSEcCtD
Tapentadol—Angioedema—Naltrexone—alcohol dependence	0.000224	0.0028	CcSEcCtD
Tapentadol—HTR3A—brain—alcohol dependence	0.000222	0.0079	CbGeAlD
Tapentadol—CYP2C9—cardiovascular system—alcohol dependence	0.000222	0.00789	CbGeAlD
Tapentadol—SLC6A4—nervous system—alcohol dependence	0.000222	0.00788	CbGeAlD
Tapentadol—Arthralgia—Acamprosate—alcohol dependence	0.000221	0.00276	CcSEcCtD
Tapentadol—Syncope—Naltrexone—alcohol dependence	0.00022	0.00275	CcSEcCtD
Tapentadol—Anxiety—Acamprosate—alcohol dependence	0.00022	0.00275	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000219	0.00274	CcSEcCtD
Tapentadol—Palpitations—Naltrexone—alcohol dependence	0.000217	0.00271	CcSEcCtD
Tapentadol—Dry mouth—Acamprosate—alcohol dependence	0.000216	0.0027	CcSEcCtD
Tapentadol—Loss of consciousness—Naltrexone—alcohol dependence	0.000216	0.00269	CcSEcCtD
Tapentadol—Cough—Naltrexone—alcohol dependence	0.000214	0.00267	CcSEcCtD
Tapentadol—Abdominal discomfort—Citalopram—alcohol dependence	0.000214	0.00267	CcSEcCtD
Tapentadol—Confusional state—Acamprosate—alcohol dependence	0.000214	0.00267	CcSEcCtD
Tapentadol—SLC6A4—central nervous system—alcohol dependence	0.000213	0.00759	CbGeAlD
Tapentadol—Convulsion—Naltrexone—alcohol dependence	0.000213	0.00266	CcSEcCtD
Tapentadol—Anaphylactic shock—Acamprosate—alcohol dependence	0.000212	0.00264	CcSEcCtD
Tapentadol—Infection—Acamprosate—alcohol dependence	0.00021	0.00263	CcSEcCtD
Tapentadol—Arthralgia—Naltrexone—alcohol dependence	0.000209	0.00261	CcSEcCtD
Tapentadol—SLC6A2—endocrine gland—alcohol dependence	0.000208	0.00742	CbGeAlD
Tapentadol—Shock—Acamprosate—alcohol dependence	0.000208	0.0026	CcSEcCtD
Tapentadol—Anxiety—Naltrexone—alcohol dependence	0.000208	0.0026	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000208	0.00259	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000208	0.00259	CcSEcCtD
Tapentadol—Tachycardia—Acamprosate—alcohol dependence	0.000207	0.00258	CcSEcCtD
Tapentadol—Pollakiuria—Citalopram—alcohol dependence	0.000206	0.00257	CcSEcCtD
Tapentadol—Skin disorder—Acamprosate—alcohol dependence	0.000206	0.00257	CcSEcCtD
Tapentadol—Erectile dysfunction—Citalopram—alcohol dependence	0.000206	0.00257	CcSEcCtD
Tapentadol—Hyperhidrosis—Acamprosate—alcohol dependence	0.000205	0.00256	CcSEcCtD
Tapentadol—Dry mouth—Naltrexone—alcohol dependence	0.000204	0.00255	CcSEcCtD
Tapentadol—CYP2D6—brainstem—alcohol dependence	0.000204	0.00725	CbGeAlD
Tapentadol—OPRM1—brain—alcohol dependence	0.000204	0.00725	CbGeAlD
Tapentadol—Confusional state—Naltrexone—alcohol dependence	0.000202	0.00252	CcSEcCtD
Tapentadol—Weight decreased—Citalopram—alcohol dependence	0.000202	0.00252	CcSEcCtD
Tapentadol—Oedema—Naltrexone—alcohol dependence	0.0002	0.0025	CcSEcCtD
Tapentadol—Anaphylactic shock—Naltrexone—alcohol dependence	0.0002	0.0025	CcSEcCtD
Tapentadol—Infection—Naltrexone—alcohol dependence	0.000199	0.00248	CcSEcCtD
Tapentadol—Infestation NOS—Citalopram—alcohol dependence	0.000199	0.00248	CcSEcCtD
Tapentadol—Infestation—Citalopram—alcohol dependence	0.000199	0.00248	CcSEcCtD
Tapentadol—SLC6A2—testis—alcohol dependence	0.000199	0.00707	CbGeAlD
Tapentadol—Depression—Citalopram—alcohol dependence	0.000198	0.00248	CcSEcCtD
Tapentadol—Hypotension—Acamprosate—alcohol dependence	0.000198	0.00247	CcSEcCtD
Tapentadol—Shock—Naltrexone—alcohol dependence	0.000197	0.00246	CcSEcCtD
Tapentadol—CYP2D6—forebrain—alcohol dependence	0.000197	0.007	CbGeAlD
Tapentadol—Nervous system disorder—Naltrexone—alcohol dependence	0.000197	0.00245	CcSEcCtD
Tapentadol—CYP2C19—endocrine gland—alcohol dependence	0.000196	0.00698	CbGeAlD
Tapentadol—Tachycardia—Naltrexone—alcohol dependence	0.000196	0.00244	CcSEcCtD
Tapentadol—SLC6A2—nervous system—alcohol dependence	0.000195	0.00694	CbGeAlD
Tapentadol—Skin disorder—Naltrexone—alcohol dependence	0.000195	0.00243	CcSEcCtD
Tapentadol—Hyperhidrosis—Naltrexone—alcohol dependence	0.000194	0.00242	CcSEcCtD
Tapentadol—Urinary tract infection—Citalopram—alcohol dependence	0.000193	0.00242	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000193	0.00241	CcSEcCtD
Tapentadol—Insomnia—Acamprosate—alcohol dependence	0.000192	0.00239	CcSEcCtD
Tapentadol—Paraesthesia—Acamprosate—alcohol dependence	0.00019	0.00237	CcSEcCtD
Tapentadol—Dyspnoea—Acamprosate—alcohol dependence	0.000189	0.00236	CcSEcCtD
Tapentadol—Somnolence—Acamprosate—alcohol dependence	0.000188	0.00235	CcSEcCtD
Tapentadol—SLC6A2—central nervous system—alcohol dependence	0.000188	0.00668	CbGeAlD
Tapentadol—Dyspepsia—Acamprosate—alcohol dependence	0.000186	0.00233	CcSEcCtD
Tapentadol—Decreased appetite—Acamprosate—alcohol dependence	0.000184	0.0023	CcSEcCtD
Tapentadol—CYP2C9—digestive system—alcohol dependence	0.000184	0.00655	CbGeAlD
Tapentadol—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000183	0.00228	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000183	0.00228	CcSEcCtD
Tapentadol—Bradycardia—Citalopram—alcohol dependence	0.000182	0.00227	CcSEcCtD
Tapentadol—Insomnia—Naltrexone—alcohol dependence	0.000181	0.00226	CcSEcCtD
Tapentadol—Constipation—Acamprosate—alcohol dependence	0.000181	0.00226	CcSEcCtD
Tapentadol—Paraesthesia—Naltrexone—alcohol dependence	0.00018	0.00225	CcSEcCtD
Tapentadol—Dyspnoea—Naltrexone—alcohol dependence	0.000179	0.00223	CcSEcCtD
Tapentadol—Somnolence—Naltrexone—alcohol dependence	0.000178	0.00222	CcSEcCtD
Tapentadol—Hallucination—Citalopram—alcohol dependence	0.000178	0.00222	CcSEcCtD
Tapentadol—Hypoaesthesia—Citalopram—alcohol dependence	0.000178	0.00222	CcSEcCtD
Tapentadol—CYP2C19—liver—alcohol dependence	0.000177	0.00629	CbGeAlD
Tapentadol—Urinary tract disorder—Citalopram—alcohol dependence	0.000176	0.0022	CcSEcCtD
Tapentadol—Connective tissue disorder—Citalopram—alcohol dependence	0.000176	0.00219	CcSEcCtD
Tapentadol—CYP2C9—blood—alcohol dependence	0.000175	0.00624	CbGeAlD
Tapentadol—Urethral disorder—Citalopram—alcohol dependence	0.000175	0.00219	CcSEcCtD
Tapentadol—Feeling abnormal—Acamprosate—alcohol dependence	0.000175	0.00218	CcSEcCtD
Tapentadol—Decreased appetite—Naltrexone—alcohol dependence	0.000174	0.00217	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000173	0.00216	CcSEcCtD
Tapentadol—Fatigue—Naltrexone—alcohol dependence	0.000173	0.00216	CcSEcCtD
Tapentadol—Visual impairment—Citalopram—alcohol dependence	0.000172	0.00215	CcSEcCtD
Tapentadol—Constipation—Naltrexone—alcohol dependence	0.000171	0.00214	CcSEcCtD
Tapentadol—SLC6A4—brain—alcohol dependence	0.000169	0.00603	CbGeAlD
Tapentadol—Urticaria—Acamprosate—alcohol dependence	0.000168	0.0021	CcSEcCtD
Tapentadol—Eye disorder—Citalopram—alcohol dependence	0.000167	0.00208	CcSEcCtD
Tapentadol—Cardiac disorder—Citalopram—alcohol dependence	0.000166	0.00207	CcSEcCtD
Tapentadol—Feeling abnormal—Naltrexone—alcohol dependence	0.000165	0.00206	CcSEcCtD
Tapentadol—Angiopathy—Citalopram—alcohol dependence	0.000162	0.00202	CcSEcCtD
Tapentadol—Immune system disorder—Citalopram—alcohol dependence	0.000161	0.00201	CcSEcCtD
Tapentadol—Mediastinal disorder—Citalopram—alcohol dependence	0.000161	0.00201	CcSEcCtD
Tapentadol—Chills—Citalopram—alcohol dependence	0.00016	0.002	CcSEcCtD
Tapentadol—Urticaria—Naltrexone—alcohol dependence	0.000159	0.00199	CcSEcCtD
Tapentadol—Mental disorder—Citalopram—alcohol dependence	0.000157	0.00195	CcSEcCtD
Tapentadol—Hypersensitivity—Acamprosate—alcohol dependence	0.000156	0.00195	CcSEcCtD
Tapentadol—Malnutrition—Citalopram—alcohol dependence	0.000156	0.00194	CcSEcCtD
Tapentadol—Tension—Citalopram—alcohol dependence	0.000153	0.00191	CcSEcCtD
Tapentadol—CYP2C9—endocrine gland—alcohol dependence	0.000152	0.00541	CbGeAlD
Tapentadol—Asthenia—Acamprosate—alcohol dependence	0.000152	0.0019	CcSEcCtD
Tapentadol—Nervousness—Citalopram—alcohol dependence	0.000151	0.00189	CcSEcCtD
Tapentadol—Pruritus—Acamprosate—alcohol dependence	0.00015	0.00187	CcSEcCtD
Tapentadol—SLC6A2—brain—alcohol dependence	0.000149	0.00531	CbGeAlD
Tapentadol—Hypersensitivity—Naltrexone—alcohol dependence	0.000148	0.00184	CcSEcCtD
Tapentadol—Vision blurred—Citalopram—alcohol dependence	0.000147	0.00183	CcSEcCtD
Tapentadol—Tremor—Citalopram—alcohol dependence	0.000146	0.00182	CcSEcCtD
Tapentadol—Diarrhoea—Acamprosate—alcohol dependence	0.000145	0.00181	CcSEcCtD
Tapentadol—Asthenia—Naltrexone—alcohol dependence	0.000144	0.00179	CcSEcCtD
Tapentadol—Agitation—Citalopram—alcohol dependence	0.000143	0.00178	CcSEcCtD
Tapentadol—Angioedema—Citalopram—alcohol dependence	0.000142	0.00177	CcSEcCtD
Tapentadol—Pruritus—Naltrexone—alcohol dependence	0.000142	0.00177	CcSEcCtD
Tapentadol—Dizziness—Acamprosate—alcohol dependence	0.00014	0.00175	CcSEcCtD
Tapentadol—Vertigo—Citalopram—alcohol dependence	0.00014	0.00174	CcSEcCtD
Tapentadol—Syncope—Citalopram—alcohol dependence	0.00014	0.00174	CcSEcCtD
Tapentadol—CYP2D6—digestive system—alcohol dependence	0.000138	0.00491	CbGeAlD
Tapentadol—Palpitations—Citalopram—alcohol dependence	0.000137	0.00172	CcSEcCtD
Tapentadol—CYP2C9—liver—alcohol dependence	0.000137	0.00488	CbGeAlD
Tapentadol—Diarrhoea—Naltrexone—alcohol dependence	0.000137	0.00171	CcSEcCtD
Tapentadol—Loss of consciousness—Citalopram—alcohol dependence	0.000137	0.00171	CcSEcCtD
Tapentadol—Cough—Citalopram—alcohol dependence	0.000136	0.00169	CcSEcCtD
Tapentadol—Convulsion—Citalopram—alcohol dependence	0.000135	0.00168	CcSEcCtD
Tapentadol—Vomiting—Acamprosate—alcohol dependence	0.000135	0.00168	CcSEcCtD
Tapentadol—Rash—Acamprosate—alcohol dependence	0.000134	0.00167	CcSEcCtD
Tapentadol—Dermatitis—Acamprosate—alcohol dependence	0.000133	0.00167	CcSEcCtD
Tapentadol—Headache—Acamprosate—alcohol dependence	0.000133	0.00166	CcSEcCtD
Tapentadol—Dizziness—Naltrexone—alcohol dependence	0.000133	0.00165	CcSEcCtD
Tapentadol—Arthralgia—Citalopram—alcohol dependence	0.000132	0.00165	CcSEcCtD
Tapentadol—Anxiety—Citalopram—alcohol dependence	0.000132	0.00165	CcSEcCtD
Tapentadol—CYP2D6—blood—alcohol dependence	0.000132	0.00468	CbGeAlD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000132	0.00164	CcSEcCtD
Tapentadol—Dry mouth—Citalopram—alcohol dependence	0.00013	0.00162	CcSEcCtD
Tapentadol—Confusional state—Citalopram—alcohol dependence	0.000128	0.0016	CcSEcCtD
Tapentadol—Vomiting—Naltrexone—alcohol dependence	0.000127	0.00159	CcSEcCtD
Tapentadol—Oedema—Citalopram—alcohol dependence	0.000127	0.00158	CcSEcCtD
Tapentadol—Anaphylactic shock—Citalopram—alcohol dependence	0.000127	0.00158	CcSEcCtD
Tapentadol—Rash—Naltrexone—alcohol dependence	0.000126	0.00158	CcSEcCtD
Tapentadol—Dermatitis—Naltrexone—alcohol dependence	0.000126	0.00158	CcSEcCtD
Tapentadol—Infection—Citalopram—alcohol dependence	0.000126	0.00157	CcSEcCtD
Tapentadol—Nausea—Acamprosate—alcohol dependence	0.000126	0.00157	CcSEcCtD
Tapentadol—Headache—Naltrexone—alcohol dependence	0.000126	0.00157	CcSEcCtD
Tapentadol—Shock—Citalopram—alcohol dependence	0.000125	0.00156	CcSEcCtD
Tapentadol—Nervous system disorder—Citalopram—alcohol dependence	0.000125	0.00155	CcSEcCtD
Tapentadol—Tachycardia—Citalopram—alcohol dependence	0.000124	0.00155	CcSEcCtD
Tapentadol—Skin disorder—Citalopram—alcohol dependence	0.000123	0.00154	CcSEcCtD
Tapentadol—Hyperhidrosis—Citalopram—alcohol dependence	0.000123	0.00153	CcSEcCtD
Tapentadol—Nausea—Naltrexone—alcohol dependence	0.000119	0.00149	CcSEcCtD
Tapentadol—Hypotension—Citalopram—alcohol dependence	0.000119	0.00148	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000116	0.00144	CcSEcCtD
Tapentadol—Insomnia—Citalopram—alcohol dependence	0.000115	0.00143	CcSEcCtD
Tapentadol—CYP2D6—endocrine gland—alcohol dependence	0.000114	0.00406	CbGeAlD
Tapentadol—Paraesthesia—Citalopram—alcohol dependence	0.000114	0.00142	CcSEcCtD
Tapentadol—Dyspnoea—Citalopram—alcohol dependence	0.000113	0.00141	CcSEcCtD
Tapentadol—Somnolence—Citalopram—alcohol dependence	0.000113	0.00141	CcSEcCtD
Tapentadol—Dyspepsia—Citalopram—alcohol dependence	0.000112	0.0014	CcSEcCtD
Tapentadol—Decreased appetite—Citalopram—alcohol dependence	0.00011	0.00138	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00011	0.00137	CcSEcCtD
Tapentadol—Fatigue—Citalopram—alcohol dependence	0.000109	0.00137	CcSEcCtD
Tapentadol—CYP2D6—testis—alcohol dependence	0.000109	0.00387	CbGeAlD
Tapentadol—Constipation—Citalopram—alcohol dependence	0.000109	0.00136	CcSEcCtD
Tapentadol—CYP2D6—nervous system—alcohol dependence	0.000107	0.0038	CbGeAlD
Tapentadol—Feeling abnormal—Citalopram—alcohol dependence	0.000105	0.00131	CcSEcCtD
Tapentadol—CYP2D6—liver—alcohol dependence	0.000103	0.00366	CbGeAlD
Tapentadol—CYP2D6—central nervous system—alcohol dependence	0.000103	0.00366	CbGeAlD
Tapentadol—Urticaria—Citalopram—alcohol dependence	0.000101	0.00126	CcSEcCtD
Tapentadol—CYP2D6—cerebellum—alcohol dependence	0.000101	0.00358	CbGeAlD
Tapentadol—Hypersensitivity—Citalopram—alcohol dependence	9.35e-05	0.00117	CcSEcCtD
Tapentadol—Asthenia—Citalopram—alcohol dependence	9.11e-05	0.00114	CcSEcCtD
Tapentadol—Pruritus—Citalopram—alcohol dependence	8.98e-05	0.00112	CcSEcCtD
Tapentadol—Diarrhoea—Citalopram—alcohol dependence	8.69e-05	0.00108	CcSEcCtD
Tapentadol—Dizziness—Citalopram—alcohol dependence	8.4e-05	0.00105	CcSEcCtD
Tapentadol—CYP2D6—brain—alcohol dependence	8.16e-05	0.0029	CbGeAlD
Tapentadol—Vomiting—Citalopram—alcohol dependence	8.07e-05	0.00101	CcSEcCtD
Tapentadol—Rash—Citalopram—alcohol dependence	8.01e-05	0.000999	CcSEcCtD
Tapentadol—Dermatitis—Citalopram—alcohol dependence	8e-05	0.000998	CcSEcCtD
Tapentadol—Headache—Citalopram—alcohol dependence	7.95e-05	0.000993	CcSEcCtD
Tapentadol—Nausea—Citalopram—alcohol dependence	7.54e-05	0.000941	CcSEcCtD
Tapentadol—OPRM1—GPCR ligand binding—DRD4—alcohol dependence	3.56e-05	0.000751	CbGpPWpGaD
Tapentadol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	3.56e-05	0.000751	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CRHR1—alcohol dependence	3.55e-05	0.00075	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	3.53e-05	0.000744	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—OPRM1—alcohol dependence	3.5e-05	0.000738	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—EP300—alcohol dependence	3.49e-05	0.000737	CbGpPWpGaD
Tapentadol—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	3.48e-05	0.000734	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PDYN—alcohol dependence	3.47e-05	0.000732	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CHRM2—alcohol dependence	3.46e-05	0.00073	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CNR1—alcohol dependence	3.4e-05	0.000717	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—OPRD1—alcohol dependence	3.37e-05	0.000711	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CHRM2—alcohol dependence	3.34e-05	0.000705	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—DRD2—alcohol dependence	3.32e-05	0.0007	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR7—alcohol dependence	3.32e-05	0.0007	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—AVP—alcohol dependence	3.3e-05	0.000697	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	3.29e-05	0.000693	CbGpPWpGaD
Tapentadol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	3.27e-05	0.00069	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	3.25e-05	0.000685	CbGpPWpGaD
Tapentadol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	3.24e-05	0.000684	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—GGT1—alcohol dependence	3.24e-05	0.000683	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PDYN—alcohol dependence	3.23e-05	0.000681	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CRHR1—alcohol dependence	3.23e-05	0.000681	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—NPY—alcohol dependence	3.22e-05	0.000679	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	3.22e-05	0.000679	CbGpPWpGaD
Tapentadol—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	3.2e-05	0.000675	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ADH7—alcohol dependence	3.2e-05	0.000675	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—OPRM1—alcohol dependence	3.18e-05	0.00067	CbGpPWpGaD
Tapentadol—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	3.17e-05	0.000669	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HTR2A—alcohol dependence	3.13e-05	0.000661	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR1B—alcohol dependence	3.11e-05	0.000655	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CRH—alcohol dependence	3.11e-05	0.000655	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—OPRM1—alcohol dependence	3.07e-05	0.000647	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GGT2—alcohol dependence	3.07e-05	0.000647	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—POMC—alcohol dependence	3.06e-05	0.000646	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—OPRD1—alcohol dependence	3.06e-05	0.000645	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ADH4—alcohol dependence	3.06e-05	0.000645	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	3.05e-05	0.000643	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CHRM2—alcohol dependence	3.03e-05	0.00064	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CRHR1—alcohol dependence	3e-05	0.000633	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—GGT1—alcohol dependence	2.98e-05	0.000629	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—GGT1—alcohol dependence	2.95e-05	0.000623	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PDYN—alcohol dependence	2.93e-05	0.000619	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—NPY—alcohol dependence	2.92e-05	0.000617	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—MAOA—alcohol dependence	2.9e-05	0.000612	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	2.88e-05	0.000608	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—EP300—alcohol dependence	2.85e-05	0.000602	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CHRM2—alcohol dependence	2.82e-05	0.000596	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—NPY—alcohol dependence	2.82e-05	0.000595	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CRH—alcohol dependence	2.82e-05	0.000595	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR1B—alcohol dependence	2.82e-05	0.000595	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ADH1B—alcohol dependence	2.81e-05	0.000592	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—AVP—alcohol dependence	2.79e-05	0.000589	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—OPRM1—alcohol dependence	2.79e-05	0.000588	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.78e-05	0.000587	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR2A—alcohol dependence	2.75e-05	0.00058	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CRHR1—alcohol dependence	2.73e-05	0.000575	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR1B—alcohol dependence	2.72e-05	0.000574	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CRH—alcohol dependence	2.72e-05	0.000574	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—DRD4—alcohol dependence	2.71e-05	0.000573	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OPRK1—alcohol dependence	2.69e-05	0.000567	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—MAOA—alcohol dependence	2.67e-05	0.000563	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—MAOA—alcohol dependence	2.65e-05	0.000558	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.65e-05	0.000558	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ADH7—alcohol dependence	2.6e-05	0.000548	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CNR1—alcohol dependence	2.59e-05	0.000547	CbGpPWpGaD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	2.57e-05	0.000543	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CHRM2—alcohol dependence	2.56e-05	0.000541	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—NPY—alcohol dependence	2.56e-05	0.000541	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—DRD2—alcohol dependence	2.53e-05	0.000533	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR7—alcohol dependence	2.53e-05	0.000533	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—POMC—alcohol dependence	2.5e-05	0.000528	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GGT2—alcohol dependence	2.49e-05	0.000526	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR1B—alcohol dependence	2.47e-05	0.000522	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CRH—alcohol dependence	2.47e-05	0.000522	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—DRD4—alcohol dependence	2.47e-05	0.00052	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	2.44e-05	0.000514	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—NPY—alcohol dependence	2.39e-05	0.000503	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—DRD4—alcohol dependence	2.38e-05	0.000502	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CNR1—alcohol dependence	2.35e-05	0.000497	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PDYN—alcohol dependence	2.34e-05	0.000493	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MAOB—alcohol dependence	2.32e-05	0.00049	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR2A—alcohol dependence	2.32e-05	0.00049	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—AVP—alcohol dependence	2.3e-05	0.000486	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR1B—alcohol dependence	2.3e-05	0.000486	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CRH—alcohol dependence	2.3e-05	0.000486	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR7—alcohol dependence	2.3e-05	0.000484	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—DRD2—alcohol dependence	2.3e-05	0.000484	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ADH1B—alcohol dependence	2.28e-05	0.000481	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CNR1—alcohol dependence	2.27e-05	0.000479	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR7—alcohol dependence	2.22e-05	0.000468	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—DRD2—alcohol dependence	2.22e-05	0.000468	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—POMC—alcohol dependence	2.19e-05	0.000463	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—WASF2—alcohol dependence	2.17e-05	0.000459	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CRHR1—alcohol dependence	2.17e-05	0.000459	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—NPY—alcohol dependence	2.17e-05	0.000457	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—DRD4—alcohol dependence	2.16e-05	0.000456	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—OPRD1—alcohol dependence	2.14e-05	0.000451	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AVP—alcohol dependence	2.13e-05	0.000449	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR1B—alcohol dependence	2.09e-05	0.000441	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CRH—alcohol dependence	2.09e-05	0.000441	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—WASF1—alcohol dependence	2.08e-05	0.00044	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CNR1—alcohol dependence	2.06e-05	0.000435	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PDYN—alcohol dependence	2.05e-05	0.000433	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CHRM2—alcohol dependence	2.04e-05	0.000431	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADH6—alcohol dependence	2.04e-05	0.00043	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR7—alcohol dependence	2.01e-05	0.000425	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—DRD2—alcohol dependence	2.01e-05	0.000425	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—DRD4—alcohol dependence	2.01e-05	0.000424	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALDH2—alcohol dependence	1.98e-05	0.000417	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AVP—alcohol dependence	1.93e-05	0.000408	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CNR1—alcohol dependence	1.92e-05	0.000405	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CRHR1—alcohol dependence	1.91e-05	0.000402	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—WASF2—alcohol dependence	1.91e-05	0.000402	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—POMC—alcohol dependence	1.89e-05	0.000399	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MAOB—alcohol dependence	1.89e-05	0.000398	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—OPRM1—alcohol dependence	1.88e-05	0.000396	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADH6—alcohol dependence	1.88e-05	0.000396	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—DRD2—alcohol dependence	1.87e-05	0.000395	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR7—alcohol dependence	1.87e-05	0.000395	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AVP—alcohol dependence	1.87e-05	0.000394	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADH6—alcohol dependence	1.86e-05	0.000392	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—POMC—alcohol dependence	1.85e-05	0.000391	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—WASF1—alcohol dependence	1.83e-05	0.000386	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—DRD4—alcohol dependence	1.83e-05	0.000385	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OPRD1—alcohol dependence	1.81e-05	0.000381	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CHRM2—alcohol dependence	1.79e-05	0.000378	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR2A—alcohol dependence	1.77e-05	0.000374	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CNR1—alcohol dependence	1.74e-05	0.000368	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—POMC—alcohol dependence	1.74e-05	0.000367	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PDYN—alcohol dependence	1.73e-05	0.000366	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NPY—alcohol dependence	1.73e-05	0.000364	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—POMC—alcohol dependence	1.72e-05	0.000364	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—DRD2—alcohol dependence	1.7e-05	0.000359	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR7—alcohol dependence	1.7e-05	0.000359	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AVP—alcohol dependence	1.69e-05	0.000358	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADH1A—alcohol dependence	1.69e-05	0.000357	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GOT2—alcohol dependence	1.68e-05	0.000355	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR1B—alcohol dependence	1.67e-05	0.000351	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CRH—alcohol dependence	1.67e-05	0.000351	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—OPRM1—alcohol dependence	1.65e-05	0.000347	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CRHR1—alcohol dependence	1.61e-05	0.00034	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—WASF2—alcohol dependence	1.61e-05	0.00034	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2A—alcohol dependence	1.61e-05	0.000339	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALDH2—alcohol dependence	1.61e-05	0.000339	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP2E1—alcohol dependence	1.58e-05	0.000333	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AVP—alcohol dependence	1.58e-05	0.000333	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADH1A—alcohol dependence	1.55e-05	0.000328	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2A—alcohol dependence	1.55e-05	0.000328	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—WASF1—alcohol dependence	1.54e-05	0.000326	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.54e-05	0.000326	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADH1A—alcohol dependence	1.54e-05	0.000325	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CHRM2—alcohol dependence	1.51e-05	0.00032	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NPY—alcohol dependence	1.51e-05	0.000319	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CRH—alcohol dependence	1.46e-05	0.000308	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR1B—alcohol dependence	1.46e-05	0.000308	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD4—alcohol dependence	1.46e-05	0.000307	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GGT1—alcohol dependence	1.45e-05	0.000306	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GOT1—alcohol dependence	1.45e-05	0.000306	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADH4—alcohol dependence	1.44e-05	0.000303	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AVP—alcohol dependence	1.43e-05	0.000302	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—POMC—alcohol dependence	1.41e-05	0.000298	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2A—alcohol dependence	1.41e-05	0.000298	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CNR1—alcohol dependence	1.39e-05	0.000293	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GOT2—alcohol dependence	1.37e-05	0.000288	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR7—alcohol dependence	1.36e-05	0.000286	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—DRD2—alcohol dependence	1.36e-05	0.000286	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADH4—alcohol dependence	1.32e-05	0.000279	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2A—alcohol dependence	1.31e-05	0.000277	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADH4—alcohol dependence	1.31e-05	0.000276	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MAOA—alcohol dependence	1.3e-05	0.000274	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—POMC—alcohol dependence	1.28e-05	0.000271	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP2E1—alcohol dependence	1.28e-05	0.000271	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPY—alcohol dependence	1.28e-05	0.00027	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD4—alcohol dependence	1.28e-05	0.000269	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.24e-05	0.000262	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—POMC—alcohol dependence	1.24e-05	0.000262	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1B—alcohol dependence	1.23e-05	0.00026	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CRH—alcohol dependence	1.23e-05	0.00026	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADH7—alcohol dependence	1.22e-05	0.000258	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CNR1—alcohol dependence	1.22e-05	0.000257	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2A—alcohol dependence	1.19e-05	0.000251	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR7—alcohol dependence	1.19e-05	0.000251	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—DRD2—alcohol dependence	1.19e-05	0.000251	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GOT1—alcohol dependence	1.18e-05	0.000249	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GGT1—alcohol dependence	1.18e-05	0.000249	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GGT2—alcohol dependence	1.17e-05	0.000247	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AVP—alcohol dependence	1.14e-05	0.000241	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.13e-05	0.000239	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—alcohol dependence	1.13e-05	0.000238	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADH7—alcohol dependence	1.12e-05	0.000237	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADH7—alcohol dependence	1.11e-05	0.000235	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD4—alcohol dependence	1.08e-05	0.000228	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GGT2—alcohol dependence	1.08e-05	0.000227	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADH1B—alcohol dependence	1.07e-05	0.000226	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GGT2—alcohol dependence	1.07e-05	0.000225	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MAOA—alcohol dependence	1.06e-05	0.000223	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—alcohol dependence	1.05e-05	0.000221	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CNR1—alcohol dependence	1.03e-05	0.000217	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.02e-05	0.000216	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—DRD2—alcohol dependence	1.01e-05	0.000212	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR7—alcohol dependence	1.01e-05	0.000212	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AVP—alcohol dependence	1e-05	0.000211	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADH1B—alcohol dependence	9.85e-06	0.000208	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADH1B—alcohol dependence	9.77e-06	0.000206	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—alcohol dependence	9.52e-06	0.000201	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2A—alcohol dependence	9.5e-06	0.0002	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MAOB—alcohol dependence	8.88e-06	0.000187	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—alcohol dependence	8.46e-06	0.000179	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AVP—alcohol dependence	8.46e-06	0.000179	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2A—alcohol dependence	8.33e-06	0.000176	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MAOB—alcohol dependence	8.17e-06	0.000172	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MAOB—alcohol dependence	8.09e-06	0.000171	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—alcohol dependence	7.59e-06	0.00016	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALDH2—alcohol dependence	7.55e-06	0.000159	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	7.26e-06	0.000153	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2A—alcohol dependence	7.04e-06	0.000149	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALDH2—alcohol dependence	6.94e-06	0.000146	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALDH2—alcohol dependence	6.88e-06	0.000145	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—alcohol dependence	6.88e-06	0.000145	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—alcohol dependence	6.65e-06	0.00014	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.62e-06	0.00014	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT2—alcohol dependence	6.42e-06	0.000135	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP2E1—alcohol dependence	6.03e-06	0.000127	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT2—alcohol dependence	5.9e-06	0.000125	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT2—alcohol dependence	5.85e-06	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—alcohol dependence	5.62e-06	0.000119	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—EP300—alcohol dependence	5.61e-06	0.000118	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP2E1—alcohol dependence	5.55e-06	0.000117	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GGT1—alcohol dependence	5.54e-06	0.000117	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT1—alcohol dependence	5.54e-06	0.000117	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP2E1—alcohol dependence	5.5e-06	0.000116	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GGT1—alcohol dependence	5.1e-06	0.000108	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT1—alcohol dependence	5.1e-06	0.000108	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT1—alcohol dependence	5.05e-06	0.000107	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GGT1—alcohol dependence	5.05e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EP300—alcohol dependence	5.03e-06	0.000106	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MAOA—alcohol dependence	4.96e-06	0.000105	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.81e-06	0.000102	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MAOA—alcohol dependence	4.57e-06	9.63e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—EP300—alcohol dependence	4.56e-06	9.62e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MAOA—alcohol dependence	4.53e-06	9.55e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EP300—alcohol dependence	4.41e-06	9.31e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.39e-06	9.26e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EP300—alcohol dependence	3.73e-06	7.87e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—alcohol dependence	3.23e-06	6.82e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—alcohol dependence	2.97e-06	6.27e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—alcohol dependence	2.95e-06	6.22e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—EP300—alcohol dependence	2.14e-06	4.52e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—EP300—alcohol dependence	1.97e-06	4.16e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—EP300—alcohol dependence	1.96e-06	4.12e-05	CbGpPWpGaD
